LGND Ligand Pharmaceuticals Incorporated - Common Stock
$289,77
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 7, 2026
52W-Spanne
$152–$327
79% of range
Analystenbewertung
BUY
15 analysts
Kursziel
$344
+19% upside
P/E (TTM)
47.9
ROE
13.5%
Nettogewinnmarge
46.4%
LGND Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$289.77
Marktkapitalisierung
$5.80B
P/E (TTM)
47.9
EPS (TTM)
$6.13
Umsatz (TTM)
$268M
Dividendenrendite
—
ROE
13.5%
Verschuldungsgrad
—
52W-Spanne
$152 – $327
LGND Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$268M
2016-12-31
→
2025-12-31
EPS
$6.13
2016-12-31
→
2025-12-31
Freier Cashflow
$49M
2016-12-31
→
2025-12-31
Margen
46.4%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
LGND
Peer-Median
P/E (TTM)
47.9
38.7
P/S (TTM) (K/V (TTM))
21.6
9.5
P/B (K/B)
5.7
3.8
Price / FCF (Kurs / FCF)
118.7
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
LGND
Peer-Median
Operating Margin (Betriebsgewinnmarge)
15.3%
—
Net Profit Margin (Nettogewinnmarge)
46.4%
15.3%
ROA
10.0%
-6.4%
ROE
13.5%
-16.8%
ROIC
3.2%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
LGND
Peer-Median
Current Ratio (Liquiditätsgrad)
22.2
12.8
Quick Ratio
21.2
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
LGND
Peer-Median
Revenue YoY (Umsatz YoY)
60.4%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
11.0%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
10.4%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
LGND
Peer-Median
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Dividendenrendite
—
Ausschüttungsquote
—
5J Div CAGR
—
| Ex-Datum | Betrag |
|---|---|
| 3. April 2007 | $9,3575 |
LGND Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
15 Analysten
- Starker Kauf 6 40,0%
- Kauf 8 53,3%
- Halten 1 6,7%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
10 Analysten · 2026-08-13
Median
$347.50
Jetzt
$289.77
Tief
$247.00
Hoch
$388.00
Median-Ziel
$347.50
+19,9%
Mittelwert-Ziel
$343.80
+18,6%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.34%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $2.37 | $1.88 | 0.49% |
| 31. März 2026 | $1.63 | $1.85 | -0.22% |
| 31. Dezember 2025 | $2.02 | $1.59 | 0.43% |
| 30. September 2025 | $3.09 | $1.96 | 1.1% |
| 30. Juni 2025 | $1.60 | $1.45 | 0.15% |
| 31. März 2025 | $1.33 | $1.24 | 0.09% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| LGND | $3.74B | 30.8 | 60.4% | 46.4% | 13.5% | — |
| AXSM | $9.29B | -49.6 | 65.5% | -28.7% | -227.0% | — |
| CRNX | $4.45B | -9.4 | 640.7% | -6046.2% | -43.0% | — |
| LQDA | $3.01B | -43.1 | 1031.2% | -43.5% | -230.0% | — |
| BLTE | — | — | — | — | — | — |
| DFTX | $1.32B | -6.5 | 212.0% | — | -71.0% | — |
| AMRX | — | 57.3 | 8.1% | 2.4% | -80.0% | 36.9% |
| EWTX | $2.64B | -15.2 | — | — | -30.2% | — |
| INDV | — | 21.9 | 4.3% | 17.0% | -118.3% | 80.2% |
| MANE | — | — | — | — | 82.6% | — |
| ELVN | $915M | -8.4 | — | — | -21.9% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $268M | $167M | $131M | $196M | $242M | $164M | $120M | $251M | $141M | $109M | $72M | $65M | |
| Cost of Revenue | · | · | · | · | · | · | · | $6M | $5M | $6M | $6M | $9M | |
| R&D Expense | $81M | $21M | $25M | $36M | $32M | $41M | $56M | $28M | $27M | $21M | $11M | $10M | |
| SG&A Expense | $92M | $79M | $53M | $70M | $47M | $60M | $42M | $38M | $29M | $28M | $25M | $23M | |
| Operating Income | $41M | $-23M | $12M | $3M | $104M | $38M | $807M | $164M | $68M | $44M | $27M | $20M | |
| Interest Expense | · | · | $656.0K | $2M | $20M | $27M | $36M | $48M | $13M | $13M | · | $5M | |
| Interest Income | $14M | $8M | $8M | $2M | $886.0K | $8M | $28M | $14M | $2M | · | · | · | |
| Other Non-op | $-89.0K | $-20M | $-2M | $4M | $-8M | $62.0K | $-4M | $-6M | $3M | $-615.0K | $2M | $2M | |
| Pretax Income | $159M | $3M | $64M | $36M | $72M | $1M | $797M | $173M | $57M | $8M | $35M | $11M | |
| Income Tax | $35M | $7M | $10M | $41M | $-4M | $-5M | $167M | $30M | $45M | $10M | $-192M | $410.0K | |
| Net Income | $124M | $-4M | $52M | $-33M | $57M | $-3M | $629M | $143M | $13M | $-2M | $230M | $12M | |
| EPS (Basic) | $6.44 | $-0.22 | $3.02 | $-1.98 | $3.44 | $-0.18 | $33.13 | $6.77 | $0.60 | $-0.08 | $11.61 | $0.59 | |
| EPS (Diluted) | $6.13 | $-0.22 | $2.94 | $-1.98 | $3.31 | $-0.18 | $31.85 | $5.96 | $0.53 | $-0.08 | $10.83 | $0.56 | |
| Shares (Basic) | 19,338,000 | 18,290,000 | 17,298,000 | 16,868,000 | 16,630,000 | 16,185,000 | 18,995,000 | 21,160,000 | 21,032,000 | 20,831,000 | 19,790,000 | 20,419,000 | |
| Shares (Diluted) | 20,294,000 | 18,290,000 | 17,757,000 | 16,868,000 | 17,246,000 | 16,825,000 | 19,757,000 | 24,067,000 | 23,481,000 | 20,831,000 | 21,228,000 | 21,433,000 | |
| EBITDA | $75M | $13M | $48M | $55M | $130M | $52M | $825M | $178M | $80M | $55M | $30M | $22M |
Bilanz 30
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $175M | $72M | $23M | $45M | $20M | $48M | $72M | $117M | $21M | $19M | $97M | $160M | |
| Short-term Investments | $559M | $184M | $147M | $167M | $322M | $364M | $998M | $601M | $181M | $122M | $103M | $7M | |
| Receivables | $60M | $38M | $33M | $30M | $85M | $57M | $30M | $56M | $26M | $15M | $6M | $13M | |
| Inventory | $9M | $14M | $24M | $13M | $27M | $26M | $7M | $7M | $4M | $2M | $2M | $269.0K | |
| Prepaid Expense | · | $2M | $1M | $1M | · | · | · | · | $1M | $2M | $1M | $835.0K | |
| Other Current Assets | $6M | $9M | $3M | $2M | $4M | $4M | $5M | $11M | $2M | $2M | $2M | $2M | |
| Current Assets | $832M | $332M | $237M | $264M | $465M | $501M | $1.12B | $871M | $237M | $163M | $215M | $185M | |
| PP&E (Net) | $4M | $15M | $16M | $12M | $13M | $13M | $7M | $5M | $4M | $2M | $372.0K | $486.0K | |
| PP&E (Gross) | $10M | $23M | $22M | $23M | $29M | $20M | $10M | $8M | $6M | $3M | $3M | $3M | |
| Accum. Depreciation | $7M | $8M | $7M | $10M | $9M | $6M | $3M | $2M | $2M | $2M | $3M | $3M | |
| Goodwill | $102M | $105M | $103M | $0 | $106M | $190M | $95M | $87M | $86M | $72M | $12M | $12M | |
| Intangibles | $225M | $267M | $300M | $342M | $377M | $595M | $210M | $220M | $229M | $205M | $48M | $51M | |
| Other Non-current Assets | $13M | $32M | $6M | $2M | $1M | $4M | $2M | $471.0K | $5M | $2M | $27.0K | $207.0K | |
| Total Assets | $1.56B | $942M | $787M | $763M | $1.30B | $1.36B | $1.49B | $1.26B | $671M | $602M | $503M | $258M | |
| Accounts Payable | $3M | $5M | $2M | $5M | $8M | $4M | $2M | $4M | $2M | $3M | $4M | $8M | |
| Accrued Liabilities | $31M | $28M | $12M | $16M | $18M | $19M | $9M | $19M | $7M | $6M | $5M | $5M | |
| Short-term Debt | · | · | · | · | · | · | · | · | $225M | $213M | $202M | $334.0K | |
| Current Liabilities | $37M | $37M | $17M | $99M | $42M | $100M | $17M | $82M | $239M | $227M | $223M | $23M | |
| Capital Leases | $4M | $6M | $6M | $10M | $2M | $6M | $10M | $0 | · | · | · | · | |
| Deferred Tax | $36M | $33M | $32M | $31M | $31M | $65M | $33M | $0 | · | · | · | $3M | |
| Other Non-current Liabilities | $17M | $30M | $28M | $28M | $22M | $31M | $22M | $951.0K | $4M | $687.0K | $297.0K | $770.0K | |
| Total Liabilities | $543M | $111M | $86M | $165M | $476M | $653M | $728M | $700M | $252M | $231M | $226M | $234M | |
| Total Debt | · | · | · | · | · | · | · | · | $225M | $213M | $202M | $334.0K | |
| Common Stock | $20.0K | $20.0K | $18.0K | $17.0K | $17.0K | $16.0K | $17.0K | $21.0K | $21.0K | $21.0K | $20.0K | $20.0K | |
| Paid-in Capital | $401M | $337M | $199M | $148M | $373M | $318M | $367M | $791M | $798M | $770M | $662M | $681M | |
| Retained Earnings | $608M | $499M | $503M | $451M | $449M | $392M | $400M | $-229M | $-401M | $-431M | $-429M | $-659M | |
| AOCI | $8M | $-6M | $-817.0K | $-984.0K | $-917.0K | $-801.0K | $-216.0K | $-1M | $2M | $3M | $5M | $5M | |
| Stockholders' Equity | $1.02B | $830M | $701M | $597M | $821M | $710M | $767M | $561M | $400M | $341M | $237M | $26M | |
| Liabilities + Equity | $1.56B | $942M | $787M | $763M | $1.30B | $1.36B | $1.49B | $1.26B | $671M | $602M | $503M | $258M | |
| Shares Outstanding | 19,774,000 | 19,106,000 | 17,556,000 | 16,951,000 | 16,767,000 | 16,080,000 | 16,823,000 | 20,766,000 | 21,148,665 | 20,909,301 | 19,949,012 | 19,575,150 |
Cashflow 17
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $34M | $35M | $37M | $52M | $51M | $26M | $18M | $13M | $11M | $11M | $3M | $3M | |
| Stock-based Comp | $47M | $41M | $26M | $60M | $39M | $31M | $25M | $21M | $25M | $19M | $12M | $11M | |
| Deferred Tax | $22M | $-16M | $10M | $30M | $-5M | $-17M | $75M | · | · | · | · | · | |
| Amort. of Intangibles | · | · | · | · | $47M | $23M | $17M | $16M | $12M | $11M | $2M | $2M | |
| Other Non-cash | $-178M | $41M | $-75M | $29M | $-60M | $1M | $-702M | $15M | $44M | $34M | $-203M | $-5M | |
| Operating Cash Flow | $49M | $97M | $50M | $138M | $79M | $55M | $-29M | $194M | $89M | $61M | $42M | $21M | |
| CapEx | $452.0K | $2M | $4M | $18M | $9M | $4M | $3M | $887.0K | $2M | $2M | $93.0K | $6.0K | |
| Investing Cash Flow | $-377M | $-144M | $-12M | $164M | $31M | $232M | $467M | $-423M | $-79M | $-134M | $-113M | $-2M | |
| Net Debt Issued | $0 | $0 | $-77M | $-261M | $-156M | $-222M | $-27M | $-218M | · | $0 | $0 | $-9M | |
| Stock Issued | $0 | $37M | $0 | $0 | · | · | · | · | · | · | · | $0 | |
| Stock Repurchased | $15M | $0 | $0 | $0 | $0 | $78M | $453M | $123M | $2M | $4M | $489.0K | $68M | |
| Net Stock Activity | $-15M | $37M | · | $0 | $0 | $-78M | $-453M | $-123M | $-2M | $-4M | $-489.0K | $-68M | |
| Financing Cash Flow | $428M | $97M | $-60M | $-276M | $-138M | $-311M | $-485M | $329M | $-8M | $-5M | $8M | $130M | |
| Net Change in Cash | $103M | $49M | $-22M | $25M | · | · | · | · | $2M | $-79M | $-63M | $149M | |
| Taxes Paid | $8M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $49M | $95M | $46M | $120M | $70M | $50M | $-32M | $193M | $91M | $61M | $42M | $21M | |
| Levered FCF | · | · | $46M | $120M | $46M | $42M | $-60M | $153M | · | · | · | $16M |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 15.3% | -13.5% | 9.1% | 1.6% | 28.5% | 13.9% | 671.0% | 65.1% | 48.2% | 40.3% | 38.0% | 30.4% | |
| Net Margin | 46.4% | -2.4% | 39.7% | -17.0% | 20.6% | -1.6% | 523.2% | 57.0% | 8.9% | -1.5% | 319.6% | 18.6% | |
| Pretax Margin | 59.3% | 1.5% | 48.5% | 18.4% | 17.1% | -5.7% | 662.3% | 68.9% | 40.6% | 7.3% | 49.1% | 17.5% | |
| EBITDA Margin | 27.9% | 7.6% | 36.9% | 27.8% | 46.9% | 27.7% | 686.2% | 71.0% | 56.5% | 50.6% | 41.7% | 34.5% | |
| ROA | 10.0% | -0.47% | 6.7% | -3.2% | 4.3% | -0.21% | 45.7% | 14.8% | 2.0% | -0.30% | · | 6.6% | |
| ROE | 13.5% | -0.48% | 7.6% | -4.7% | 7.0% | -0.42% | 77.8% | 22.7% | 3.4% | -0.57% | · | 31.7% | |
| ROIC | 3.2% | 4.4% | 1.4% | -0.07% | 11.6% | 1.0% | 83.1% | 24.1% | 2.4% | -2.4% | 87.1% | 71.0% |
Liquidität & Solvenz 4
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 22.2 | 8.9 | 14.1 | 2.7 | 11.2 | 5.0 | 66.1 | 10.6 | 1.0 | 0.7 | · | 8.1 | |
| Quick Ratio | 21.2 | 7.9 | 12.1 | 2.5 | 10.2 | 4.7 | 61.3 | 9.4 | 1.0 | 0.7 | · | 7.9 | |
| Debt / Equity | · | · | · | · | · | · | · | · | 0.6 | 0.6 | · | 0.0 | |
| Interest Coverage | · | · | 18.2 | 1.7 | 4.0 | 0.9 | 22.6 | 3.4 | · | · | · | 4.0 |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.3 | 0.2 | 0.2 | · | 0.4 | |
| Inventory Turnover | · | · | · | · | · | · | · | 1.1 | 1.7 | 3.1 | · | 11.0 | |
| Receivables Turnover | 5.5 | 4.7 | 4.1 | 3.4 | 3.9 | 4.3 | 2.8 | 6.2 | 7.0 | 10.4 | · | 8.7 |
Wachstumsraten 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 60.4% | 27.3% | -33.1% | -18.8% | 47.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 11.0% | -11.6% | -7.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.4% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $268M | $167M | $131M | $196M | $242M | $164M | $120M | $251M | $141M | $109M | $72M | $65M | |
| Net Income TTM | $124M | $-4M | $52M | $-33M | $57M | $-3M | $629M | $143M | $13M | $-2M | $230M | $12M | |
| Market Cap | $3.74B | $2.05B | $1.25B | $1.13B | $1.62B | $998M | $1.09B | $1.76B | $1.81B | $1.33B | · | $650M | |
| Enterprise Value | · | · | · | · | · | · | · | · | $1.83B | $1.40B | · | $483M | |
| P/E | 30.8 | -487.0 | 24.3 | -33.7 | 29.1 | -344.7 | 2.0 | 14.2 | 161.2 | -792.3 | 6.2 | 59.3 | |
| P/S | 13.9 | 12.2 | 9.5 | 5.8 | 6.7 | 6.1 | 9.1 | 7.0 | 12.8 | 12.2 | · | 10.1 | |
| P/B | 3.7 | 2.5 | 1.8 | 1.9 | 2.0 | 1.4 | 1.4 | 3.1 | 4.5 | 3.9 | · | 24.7 | |
| P / Tangible Book | 5.4 | 4.5 | 4.2 | 4.4 | 4.8 | · | · | · | · | · | · | · | |
| P / Cash Flow | 75.7 | 21.1 | 25.3 | 8.2 | 20.5 | 18.3 | -37.3 | 9.1 | 19.3 | 21.0 | · | 31.6 | |
| P / FCF | 76.4 | 21.5 | 27.2 | 9.4 | 23.1 | 19.9 | -34.3 | 9.1 | 19.8 | 21.7 | · | 31.6 | |
| EV / EBITDA | · | · | · | · | · | · | · | · | 22.9 | 25.3 | · | 21.7 | |
| EV / FCF | · | · | · | · | · | · | · | · | 20.0 | 22.8 | · | 23.5 | |
| EV / Revenue | · | · | · | · | · | · | · | · | 13.0 | 12.8 | · | 7.5 | |
| Earnings Yield | 3.2% | -0.21% | 4.1% | -3.0% | 3.4% | -0.29% | 49.0% | 7.0% | 0.62% | -0.13% | 16.0% | 1.7% |
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $64M | $52M | $60M | $115M | $48M | $45M | $43M | $52M | $42M | $31M | $28M | $33M | $26M | $44M | $50M | $59M | |
| R&D Expense | $15M | $2M | $4M | $21M | $7M | $50M | $4M | $6M | $5M | $6M | $5M | $6M | $7M | $7M | $9M | $9M | |
| SG&A Expense | $29M | $21M | $25M | $28M | $20M | $19M | $26M | $24M | $18M | $11M | $16M | $15M | $11M | $11M | $31M | $15M | |
| Operating Income | $9M | $17M | $14M | $55M | $8M | $-36M | $-10M | $3M | $-19M | $3M | $-3M | $3M | $-2M | $14M | $-20M | $12M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $141.0K | · | $1.0K | $284.0K | $240.0K | · | $332.0K | |
| Interest Income | $7M | $7M | $6M | $4M | $2M | $2M | $2M | $1M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $591.0K | |
| Other Non-op | $3M | $-1M | $1M | $-443.0K | $1M | $-3M | $25M | $-9M | $-34M | $-2M | $3M | $-4M | $-873.0K | $603.0K | $-793.0K | $677.0K | |
| Pretax Income | $64M | $-24M | $57M | $141M | $11M | $-50M | $-39M | $-6M | $-65M | $113M | $17M | $-12M | $3M | $56M | $24M | $12M | |
| Income Tax | $16M | $-11M | $12M | $24M | $6M | $-8M | $-8M | $833.0K | $-13M | $27M | $-1M | $-2M | $881.0K | $12M | $39M | $3M | |
| Net Income | $49M | $-13M | $45M | $117M | $5M | $-42M | $-31M | $-7M | $-52M | $86M | $18M | $-10M | $2M | $42M | $-17M | $404.0K | |
| EPS (Basic) | $2.42 | $-0.67 | $2.41 | $5.99 | $0.25 | $-2.21 | $-1.81 | $-0.39 | $-2.88 | $4.86 | $1.02 | $-0.59 | $0.13 | $2.46 | $-1.04 | $0.02 | |
| EPS (Diluted) | $2.22 | $-0.67 | $2.42 | $5.68 | $0.24 | $-2.21 | $-1.70 | $-0.39 | $-2.88 | $4.75 | $1.07 | $-0.59 | $0.13 | $2.33 | $-1.04 | $0.02 | |
| Shares (Basic) | 20,063,000 | 19,883,000 | -38,758,000 | 19,578,000 | 19,327,000 | 19,191,000 | -35,889,000 | 18,419,000 | 18,028,000 | 17,732,000 | -34,421,000 | 17,380,000 | 17,276,000 | 17,063,000 | -33,712,000 | 16,888,000 | |
| Shares (Diluted) | 21,837,000 | 19,883,000 | -39,452,000 | 20,629,000 | 19,926,000 | 19,191,000 | -36,279,000 | 18,419,000 | 18,028,000 | 18,122,000 | -35,327,000 | 17,380,000 | 17,730,000 | 17,974,000 | -34,146,000 | 17,132,000 | |
| EBITDA | $9M | $26M | · | $55M | $8M | $-27M | · | $3M | $-19M | $12M | · | $3M | $-2M | $24M | · | $636.0K |
Bilanz 29
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.01B | $115M | $175M | $139M | $68M | $48M | $72M | $64M | $18M | $50M | · | $19M | $28M | $89M | · | $4M | |
| Short-term Investments | $351M | $664M | $559M | $525M | $177M | $161M | $184M | $156M | $209M | $260M | · | $171M | $191M | $194M | · | $117M | |
| Receivables | $67M | $53M | $60M | $58M | $41M | $38M | $38M | $34M | $37M | $28M | · | $36M | $28M | $29M | · | $65M | |
| Inventory | $10M | $13M | $9M | $12M | $15M | $15M | $14M | $17M | $19M | $21M | · | $25M | $27M | $14M | · | $22M | |
| Prepaid Expense | · | · | · | · | · | · | · | $2M | $2M | $1M | · | · | · | · | · | · | |
| Other Current Assets | $6M | $6M | $6M | $7M | $5M | $13M | $9M | $20M | $7M | $7M | · | $2M | $3M | $2M | · | $11M | |
| Current Assets | $1.46B | $865M | $832M | $754M | $353M | $309M | $332M | $309M | $312M | $369M | · | $254M | $277M | $328M | · | $220M | |
| PP&E (Net) | $3M | $3M | $4M | $3M | $4M | $4M | $15M | $15M | $15M | $15M | · | $16M | $11M | $12M | · | $33M | |
| PP&E (Gross) | · | · | $10M | · | · | · | $23M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $7M | · | · | · | $8M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $102M | $102M | $102M | $102M | $102M | $102M | $105M | $105M | $105M | $105M | · | $104M | $106M | $106M | $0 | $181M | |
| Intangibles | $209M | $217M | $225M | $234M | $250M | $258M | $267M | $275M | $283M | $291M | · | $315M | $325M | $334M | · | $517M | |
| Other Non-current Assets | $12M | $13M | $13M | $3M | $9M | $8M | $32M | $8M | $12M | $11M | · | $8M | $4M | $5M | · | $6M | |
| Total Assets | $2.19B | $1.53B | $1.56B | $1.48B | $949M | $905M | $942M | $955M | $866M | $914M | · | $769M | $758M | $811M | · | $1.05B | |
| Accounts Payable | $9M | $5M | $3M | $4M | $9M | $5M | $5M | $5M | $2M | $2M | · | $2M | $10M | $6M | · | $16M | |
| Accrued Liabilities | $32M | $32M | $31M | $24M | $17M | $24M | $28M | $16M | $12M | $12M | · | $11M | $7M | $15M | · | $19M | |
| Current Liabilities | $47M | $41M | $37M | $31M | $65M | $59M | $37M | $25M | $19M | $18M | · | $16M | $29M | $99M | · | $135M | |
| Capital Leases | $4M | $4M | $4M | $4M | $5M | $4M | $6M | $6M | $6M | $5M | · | $6M | $11M | $11M | · | $35M | |
| Deferred Tax | $22M | $23M | $36M | $23M | $32M | $29M | $33M | $46M | $30M | $51M | · | $33M | $28M | $30M | · | $30M | |
| Other Non-current Liabilities | $17M | $17M | $17M | $20M | $14M | $14M | $30M | $30M | $29M | $28M | · | $44M | $22M | $22M | $28M | $22M | |
| Total Liabilities | $1.22B | $535M | $543M | $527M | $120M | $110M | $111M | $114M | $91M | $107M | · | $101M | $93M | $165M | · | $234M | |
| Long-term Debt | $1.13B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $20.0K | $19.0K | $19.0K | $18.0K | · | $18.0K | $17.0K | $17.0K | · | $17.0K | |
| Paid-in Capital | $380M | $397M | $401M | $363M | $359M | $341M | $337M | $309M | $239M | $218M | · | $184M | $171M | $154M | · | $349M | |
| Retained Earnings | $583M | $595M | $608M | $578M | $461M | $457M | $499M | $530M | $537M | $589M | · | $485M | $495M | $493M | · | $468M | |
| AOCI | $4M | $5M | $8M | $9M | $8M | $-2M | $-6M | $2M | $-935.0K | $-910.0K | · | $-944.0K | $-967.0K | $-935.0K | · | $-1M | |
| Stockholders' Equity | $968M | $997M | $1.02B | $950M | $829M | $796M | $830M | $841M | $775M | $807M | $701M | $668M | $665M | $646M | $597M | $816M | |
| Liabilities + Equity | $2.19B | $1.53B | $1.56B | $1.48B | $949M | $905M | $942M | $955M | $866M | $914M | · | $769M | $758M | $811M | · | $1.05B | |
| Shares Outstanding | 19,920,000 | 20,029,000 | 19,774,000 | 19,656,000 | 19,411,000 | 19,276,000 | 19,106,000 | 18,760,000 | 18,103,000 | 17,924,000 | 17,556,000 | 17,421,000 | 17,352,000 | 17,134,000 | 16,951,000 | 16,894,000 |
Cashflow 13
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $8M | $8M | $8M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $11M | $13M | |
| Stock-based Comp | $14M | $11M | $14M | $15M | $10M | $8M | $8M | $15M | $11M | $7M | $6M | $7M | $7M | $6M | $29M | $13M | |
| Other Non-cash | · | $43M | · | · | · | $400.0K | · | · | · | $-84M | · | · | · | $-23M | · | · | |
| Operating Cash Flow | $24M | $49M | $46M | $13M | $16M | $-25M | $28M | $37M | $13M | $19M | $8M | $8M | $-82.0K | $34M | $53M | $20M | |
| CapEx | $26.0K | $228.0K | $9.0K | $15.0K | $214.0K | $214.0K | $712.0K | $596.0K | $408.0K | $105.0K | $417.0K | $487.0K | $203.0K | $2M | $2M | $4M | |
| Investing Cash Flow | $321M | $-94M | $-18M | $-353M | $-11M | $5M | $-39M | $-47M | $-55M | $-4M | $-10M | $-20M | $8M | $11M | $-7M | $19M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Stock Issued | · | · | $0 | · | · | · | $3M | · | · | · | $0 | · | · | · | · | · | |
| Stock Repurchased | · | · | $0 | $15M | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $546M | $-14M | $8M | $410M | $15M | $-5M | $20M | $55M | $9M | $12M | $5M | $3M | $-68M | $-775.0K | $-5M | $-41M | |
| Net Change in Cash | $892M | $-60M | · | · | $20M | $-24M | $9M | $45M | $-32M | $27M | $3M | $-9M | $-60M | $44M | $41M | $-1M | |
| Free Cash Flow | · | $48M | · | · | · | $-26M | · | · | · | $19M | · | · | · | $32M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $19M | · | · | · | $31M | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 13.5% | 33.6% | · | 47.6% | 17.7% | -79.9% | · | 6.1% | -46.0% | 9.7% | · | 9.4% | -7.5% | 32.3% | · | 0.96% | |
| Net Margin | 76.2% | -25.8% | · | 101.6% | 10.2% | -93.6% | · | -13.8% | -125.0% | 278.1% | · | -31.3% | 8.7% | 95.4% | · | 0.61% | |
| Pretax Margin | 101.0% | -46.9% | · | 122.2% | 23.6% | -110.7% | · | -12.2% | -157.4% | 366.2% | · | -37.0% | 12.0% | 126.3% | · | 1.3% | |
| EBITDA Margin | 13.5% | 49.5% | · | 47.6% | 17.7% | -60.5% | · | 6.1% | -46.0% | 37.9% | · | 9.4% | -7.5% | 53.9% | · | 0.96% | |
| ROA | 3.1% | -1.1% | · | 9.7% | 0.53% | -4.7% | · | -0.83% | -6.4% | 10.0% | · | -1.1% | 0.25% | 4.4% | · | 0.03% | |
| ROE | 5.4% | -1.5% | · | 13.1% | 0.60% | -5.3% | · | -0.95% | -7.2% | 11.9% | · | -1.4% | 0.31% | 5.8% | · | 0.05% | |
| ROIC | 0.67% | 0.96% | · | 4.8% | 0.44% | -3.9% | · | 0.42% | -2.0% | 0.28% | · | 0.39% | -0.22% | 1.7% | · | 0.04% |
Liquidität & Solvenz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 31.2 | 21.3 | · | 24.7 | 5.5 | 5.3 | · | 12.5 | 16.8 | 20.7 | · | 16.2 | 9.4 | 3.3 | · | 1.6 | |
| Quick Ratio | 30.5 | 20.5 | · | 23.6 | 4.4 | 4.2 | · | 10.3 | 14.2 | 19.0 | · | 14.4 | 8.4 | 3.2 | · | 1.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 21.2 | · | 3078.0 | -7.0 | 59.2 | · | 1.9 |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | |
| Receivables Turnover | 1.2 | 1.1 | · | 2.5 | 1.2 | 1.4 | · | 1.5 | 1.3 | 1.1 | · | 0.6 | 0.6 | 1.2 | · | 1.0 |
Bewertung (TTM) 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $279M | $260M | · | $260M | $186M | $170M | · | $157M | $132M | $134M | · | $154M | $180M | $204M | · | $202M | |
| Net Income TTM | $157M | $66M | · | $72M | $-97M | $-15M | · | $17M | $26M | $120M | · | $16M | $27M | $24M | · | $-21M | |
| Market Cap | $6.30B | $4.00B | · | $3.48B | $2.21B | $2.03B | · | $1.88B | $1.53B | $1.31B | · | $1.04B | $1.25B | $1.26B | · | $908M | |
| P/E | 42.3 | 65.7 | · | 53.4 | -21.7 | -144.0 | · | 112.5 | 59.8 | 11.0 | · | 31.7 | 29.7 | 52.9 | · | -383.7 | |
| P/S | 22.6 | 15.4 | · | 13.4 | 11.8 | 11.9 | · | 11.9 | 11.6 | 9.8 | · | 6.8 | 7.0 | 6.2 | · | 4.5 | |
| P/B | 6.5 | 4.0 | · | 3.7 | 2.7 | 2.5 | · | 2.2 | 2.0 | 1.6 | · | 1.6 | 1.9 | 2.0 | · | 1.1 | |
| P / Tangible Book | 9.6 | 5.9 | · | 5.7 | 4.6 | 4.7 | · | 4.1 | 3.9 | 3.2 | · | 4.2 | 5.4 | 6.1 | · | 7.7 | |
| P / Cash Flow | · | 82.1 | · | · | · | -79.6 | · | · | · | 69.9 | · | · | · | 37.1 | · | · | |
| P / FCF | · | 82.5 | · | · | · | -79.0 | · | · | · | 70.3 | · | · | · | 40.0 | · | · | |
| Earnings Yield | 2.4% | 1.5% | · | 1.9% | -4.6% | -0.69% | · | 0.89% | 1.7% | 9.1% | · | 3.1% | 3.4% | 1.9% | · | -0.26% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $268M | $167M | $131M | $196M | $242M |
| Betriebsgewinnmarge % | 15.3% | -13.5% | 9.1% | 1.6% | 28.5% |
| Nettoergebnis | $124M | $-4M | $52M | $-33M | $57M |
| Verwässerte EPS | $6.13 | $-0.22 | $2.94 | $-1.98 | $3.31 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 22.2 | 8.9 | 14.1 | 2.7 | 11.2 |
| Quick Ratio | 21.2 | 7.9 | 12.1 | 2.5 | 10.2 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $49M | $95M | $46M | $120M | $70M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 443 Einreicher · $4.3B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 105 (+43 vs. Vorquartal) | 31 (-14 vs. Vorquartal) | 137 (+17 vs. Vorquartal) | 109 (-3 vs. Vorquartal) | +2.6M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD PORTFOLIO MANAGEMENT LLC | $359.810.304 | 1.138.316 | 8,40% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $275.298.586 | 870.950 | 6,42% | Aktien |
| STATE STREET CORP | $261.251.813 | 826.539 | 6,10% | Aktien |
| FMR LLC | $231.737.274 | 733.137 | 5,41% | Aktien |
| CONGRESS ASSET MANAGEMENT CO | $208.591.268 | 659.911 | 4,87% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $179.656.000 | 568.371 | 4,19% | Aktien |
| Chicago Capital, LLC | $174.935.212 | 553.435 | 4,08% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $162.860.291 | 515.140 | 3,80% | Aktien |
| Stephens Investment Management Group LLC | $150.335.249 | 475.609 | 3,51% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $129.680.348 | 410.264 | 3,03% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $118.774.611 | 375.762 | 2,77% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $116.953.300 | 3.700 | 2,73% | Kaufoption |
| RICE HALL JAMES & ASSOCIATES, LLC | $85.360.737 | 270.052 | 1,99% | Aktien |
| Ranger Investment Management, L.P. | $81.423.520 | 257.596 | 1,90% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $80.212.263 | 253.764 | 1,87% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $78.452.590 | 248.197 | 1,83% | Aktien |
| LOOMIS SAYLES & CO L P | $76.697.342 | 242.644 | 1,79% | Aktien |
| NEXT CENTURY GROWTH INVESTORS LLC | $62.757.140 | 198.542 | 1,46% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $61.080.599 | 193.238 | 1,43% | Aktien |
| Private Capital Management, LLC | $52.475.997 | 166.016 | 1,22% | Aktien |
| VILLERE ST DENIS J & CO LLC | $49.153.891 | 155.506 | 1,15% | Aktien |
| Granahan Investment Management, LLC | $46.538.247 | 147.231 | 1,09% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $45.177.479 | 142.926 | 1,05% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $43.385.881 | 137.258 | 1,01% | Aktien |
| ASHFORD CAPITAL MANAGEMENT INC | $41.440.352 | 207.565 | 0,97% | Aktien |
| Impax Asset Management Group plc | $41.091.700 | 130.000 | 0,96% | Aktien |
| Fisher Asset Management, LLC | $38.386.026 | 121.440 | 0,90% | Aktien |
| Driehaus Capital Management LLC | $37.455.717 | 118.497 | 0,87% | Aktien |
| Penn Capital Management Company, LLC | $31.748.435 | 100.337 | 0,74% | Aktien |
| Aberdeen Group plc | $30.564.955 | 96.697 | 0,71% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $29.735.218 | 94.072 | 0,69% | Aktien |
| FIRST TRUST ADVISORS LP | $28.730.368 | 90.893 | 0,67% | Aktien |
| GOLDMAN SACHS GROUP INC | $25.743.318 | 81.443 | 0,60% | Aktien |
| VANGUARD GROUP INC | $23.737.549 | 125.549 | 0,55% | Aktien |
| AMERIPRISE FINANCIAL INC | $23.554.423 | 74.519 | 0,55% | Aktien |
| Public Sector Pension Investment Board | $21.774.808 | 68.888 | 0,51% | Aktien |
| CITIGROUP INC | $20.697.573 | 65.480 | 0,48% | Aktien |
| CASTLEARK MANAGEMENT LLC | $19.611.172 | 62.043 | 0,46% | Aktien |
| NOMURA HOLDINGS INC | $19.577.982 | 61.938 | 0,46% | Aktien |
| Dana Investment Advisors, Inc. | $18.181.497 | 57.520 | 0,42% | Aktien |
| D. E. Shaw & Co., Inc. | $17.863.826 | 56.515 | 0,42% | Aktien |
| JANUS HENDERSON GROUP PLC | $17.557.217 | 87.949 | 0,41% | Aktien |
| Granite Investment Partners, LLC | $17.109.320 | 54.128 | 0,40% | Aktien |
| RHUMBLINE ADVISERS | $15.843.977 | 50.125 | 0,37% | Aktien |
| Emerald Investment Advisers, LLC | $14.831.259 | 46.921 | 0,35% | Aktien |
| Context Capital Management, LLC | $14.540.140 | 46.000 | 0,34% | Aktien |
| PRUDENTIAL FINANCIAL INC | $14.389.365 | 45.523 | 0,34% | Aktien |
| SUSQUEHANNA ADVISORS GROUP, INC. | $14.097.614 | 44.600 | 0,33% | Aktien |
| KORNITZER CAPITAL MANAGEMENT INC /KS | $14.076.120 | 44.532 | 0,33% | Aktien |
| WCM INVESTMENT MANAGEMENT, LLC | $13.996.763 | 44.570 | 0,33% | Aktien |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $13.771.093 | 43.567 | 0,32% | Aktien |
| BANK OF AMERICA CORP /DE/ | $13.748.019 | 43.494 | 0,32% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $12.754.231 | 40.350 | 0,30% | Aktien |
| Pembroke Management, LTD | $12.731.157 | 40.277 | 0,30% | Aktien |
| Swiss National Bank | $12.327.510 | 39.000 | 0,29% | Aktien |
| ARISTEIA CAPITAL, L.L.C. | $11.774.353 | 37.250 | 0,27% | Aktien |
| CAPTRUST FINANCIAL ADVISORS | $10.939.038 | 34.607 | 0,26% | Aktien |
| Congress Wealth Management LLC / DE / | $10.733.322 | 94.417 | 0,25% | Aktien |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $10.699.962 | 33.851 | 0,25% | Aktien |
| KENNEDY CAPITAL MANAGEMENT LLC | $10.542.550 | 33.353 | 0,25% | Aktien |
| Uniplan Investment Counsel, Inc. | $10.495.472 | 33.204 | 0,24% | Aktien |
| Clark Capital Management Group, Inc. | $10.414.533 | 32.948 | 0,24% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $10.304.534 | 32.600 | 0,24% | Verkaufsoption |
| Legal & General Group Plc | $9.704.596 | 30.702 | 0,23% | Aktien |
| Moody Aldrich Partners LLC | $8.901.094 | 28.160 | 0,21% | Aktien |
| Linden Advisors LP | $8.669.084 | 27.426 | 0,20% | Aktien |
| Hodges Capital Management Inc. | $7.410.414 | 23.444 | 0,17% | Aktien |
| VOYA INVESTMENT MANAGEMENT LLC | $7.344.667 | 23.236 | 0,17% | Aktien |
| Squarepoint Ops LLC | $7.206.852 | 22.800 | 0,17% | Aktien |
| ISTHMUS PARTNERS, LLC | $6.617.344 | 20.935 | 0,15% | Aktien |
| Moran Wealth Management, LLC | $6.253.208 | 19.783 | 0,15% | Aktien |
| LAZARD ASSET MANAGEMENT LLC | $6.214.013 | 19.659 | 0,14% | Aktien |
| Informed Momentum Co LLC | $6.163.123 | 19.498 | 0,14% | Aktien |
| TD Waterhouse Canada Inc. | $6.121.719 | 19.625 | 0,14% | Aktien |
| PALISADE CAPITAL MANAGEMENT, LP | $6.023.727 | 19.057 | 0,14% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $5.950.394 | 18.825 | 0,14% | Aktien |
| Lisanti Capital Growth, LLC | $5.925.739 | 18.747 | 0,14% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $5.897.923 | 18.659 | 0,14% | Aktien |
| MORGAN STANLEY | $5.822.378 | 18.420 | 0,14% | Aktien |
| WOODSTOCK CORP | $5.798.671 | 18.345 | 0,14% | Aktien |
| MARTINGALE ASSET MANAGEMENT L P | $5.551.173 | 17.562 | 0,13% | Aktien |
| Calamos Advisors LLC | $5.437.696 | 17.203 | 0,13% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $5.409.517 | 27.095 | 0,13% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $5.189.250 | 16.417 | 0,12% | Aktien |
| BlackRock, Inc. | $4.991.693 | 15.792 | 0,12% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $4.962.613 | 15.700 | 0,12% | Kaufoption |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $4.748.476 | 23.784 | 0,11% | Aktien |
| Future Fund LLC | $4.647.787 | 14.704 | 0,11% | Aktien |
| OSAIC HOLDINGS, INC. | $4.253.131 | 13.456 | 0,10% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $4.020.665 | 12.720 | 0,09% | Aktien |
| NFJ INVESTMENT GROUP, LLC | $4.004.860 | 12.670 | 0,09% | Aktien |
| Quantinno Capital Management LP | $3.832.275 | 12.124 | 0,09% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3.808.568 | 12.049 | 0,09% | Aktien |
| NORDEA INVESTMENT MANAGEMENT AB | $3.774.807 | 11.863 | 0,09% | Aktien |
| COOKSON PEIRCE & CO INC | $3.736.816 | 11.822 | 0,09% | Aktien |
| Corient Private Wealth LP | $3.697.924 | 11.699 | 0,09% | Aktien |
| MetLife Investment Management, LLC | $3.692.879 | 11.683 | 0,09% | Aktien |
| CONNORS INVESTOR SERVICES INC | $3.439.059 | 10.880 | 0,08% | Aktien |
| JANE STREET GROUP, LLC | $3.192.509 | 10.100 | 0,07% | Kaufoption |
| CITADEL ADVISORS LLC | $3.160.900 | 10.000 | 0,07% | Kaufoption |
Unternehmensinsider 47 Insider · 16 Führungskräfte · 22 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Todd C Davis | Chief Executive Officer | 30. Juni 2026 J | 199.513 | 0 | 0 | $0 |
| David E Robinson | Pres, CEO & Chairman | 10. März 2006 A | 411.725 | 0 | 0 | $0 |
| Nishan M Desilva | VP, Finance & Strategy and CFO | 14. Mai 2015 M | 22.282 | 0 | 0 | $0 |
| John P Sharp | VP Finance and CFO | 12. Februar 2014 M | 17.667 | 0 | 0 | $0 |
| Paul V Maier | Sr. V-P, CFO | 20. November 2006 M | 84.951 | 0 | 0 | $0 |
| Matthew E Korenberg | PRESIDENT & CHIEF OPERATING | 30. Juni 2023 J | 99.124 | 0 | 0 | $0 |
| Melanie J Herman | Director of Accounting | 30. Juni 2016 J | 3.454 | 0 | 0 | $0 |
| Syed Kazmi | VP, Bus. Dev. & Strategic Plan | 9. Februar 2012 A | 18.230 | 0 | 0 | $0 |
| Martin Meglasson | V-P, Discovery Research | 11. Mai 2010 P | 102.250 | 0 | 0 | $0 |
| Zofia E Dziewanowska | VP, Clinical Research | 25. Februar 2009 S | 33.977 | 0 | 0 | $0 |
| William A Petttit | Sr. V-P, HR and Administration | 15. Dezember 2006 M | 889 | 0 | 0 | $0 |
| Eric S Groves | V-P, Project Management | 15. Dezember 2006 M | 5.127 | 0 | 0 | $0 |
| Andres Negro-Vilar | Exe V-P, R & D, CSO | 14. Dezember 2006 M | 7.233 | 0 | 0 | $0 |
| Taylor Crouch | Sr. V-P, Ops & Pres. Int'l | 5. Dezember 2006 M | 0 | 0 | 0 | $0 |
| Tod Mertes | V-P, Controller & Treasurer | 10. März 2006 A | 1.476 | 0 | 0 | $0 |
| James J Litalien | Sr. V-P, Reg Affairs & Comp. | 10. März 2006 A | 0 | 0 | 0 | $0 |
| Stephen L Sabba | Direktor | 16. Juni 2026 M | 33.629 | 0 | 3 | $-1.162.551 |
| John L Lamattina | Direktor | 10. Juni 2026 S | 26.969 | 0 | 4 | $-1.151.786 |
| Martine Zimmermann | Direktor | 5. Juni 2026 F | 5.097 | 0 | 0 | $0 |
| Nancy Ryan Gray | Direktor | 5. Juni 2026 A | 8.930 | 0 | 0 | $0 |
| Jason Aryeh | Direktor | 5. Juni 2026 A | 102.580 | 0 | 2 | $-1.250.000 |
| John W Kozarich | Direktor | 5. Juni 2026 A | 42.622 | 0 | 0 | $0 |
| Ligand Pharmaceuticals Incorporated | Direktor | 17. Dezember 2025 A | 1.500.000 | 0 | 0 | $0 |
| John L Higgins | Direktor | 28. Dezember 2022 F | 417.695 | 0 | 0 | $0 |
| David M Knott | Direktor | 17. August 2015 S | 66.152 | 0 | 0 | $0 |
| Steven J Burakoff | Direktor | 29. Mai 2009 A | 15.000 | 0 | 0 | $0 |
| Bruce Peacock | Direktor | 23. Dezember 2008 A | 10.000 | 0 | 0 | $0 |
| Jeffrey R Perry | Direktor | 29. Mai 2008 A | 33.953 | 0 | 0 | $0 |
| Elizabeth M Greetham | Direktor | 29. Mai 2008 A | 10.000 | 0 | 0 | $0 |
| Henry F Blissenbach | Direktor | 2. April 2007 M | 15.005 | 0 | 0 | $0 |
| Brigette Roberts | Direktor | 3. Januar 2007 A | 2.378 | 0 | 0 | $0 |
| Irving S Johnson | Direktor | 3. Januar 2007 A | 22.929 | 0 | 0 | $0 |
| Alexander D Cross | Direktor | 3. Januar 2007 A | 26.335 | 0 | 0 | $0 |
| John Groom | Direktor | 27. September 2006 A | 16.237 | 0 | 0 | $0 |
| Carl C Peck | Direktor | 27. September 2006 A | 8.378 | 0 | 0 | $0 |
| Michael A Rocca | Direktor | 27. September 2006 A | 11.676 | 0 | 0 | $0 |
| Octavio Espinoza | — | 12. August 2026 M | 27.696 | 0 | 1 | $-9.241.070 |
| Jason Haas | — | 12. August 2026 M | 3.981 | 0 | 3 | $-3.741.401 |
| Andrew Reardon | — | 3. August 2026 M | 41.514 | 0 | 19 | $-3.121.290 |
| Jennifer R. Cochran | — | 1. November 2022 D | 1.161 | 0 | 0 | $0 |
| Sarah Boyce | — | 1. November 2022 D | 2.892 | 0 | 0 | $0 |
| Sunil Patel | — | 1. November 2022 D | 28.820 | 0 | 0 | $0 |
| Charles S Berkman | — | 1. November 2022 D | 23.825 | 0 | 0 | $0 |
| Matthew W Foehr | — | 1. November 2022 D | 162.187 | 0 | 0 | $0 |
| Loeb, Daniel S. | — | 26. März 2007 S | 2.027.378 | 0 | 0 | $0 |
| Warner R Broaddus | — | 17. November 2006 M | 0 | 0 | 0 | $0 |
| Giambattista Aliprandi | — | 1. Juni 2004 A | — | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 18 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Ligand Pharmaceuticals Incorporated ×10 Einreichungen | 1. Mai 2026 | 47,00% | Erste Einreichung | — | SEC |
| David M. Knott, Dorset Management Corporation ×8 Einreichungen | 24. Mai 2016 | — | Erste Einreichung | Vorstandskampagne | SEC |
| Ligand Pharmaceuticals Incorporated (2) ×4 Einreichungen | 28. Januar 2010 | — | Erste Einreichung | — | SEC |
| Noonday Asset Management, L.P., Noonday G.P. (U.S.), L.L.C., Noonday Capital, L.L.C., David I. Cohen, Saurabh K. Mittal, Noonday Capital Partners, L.L.C., Farallon Capital Partners, L.P., Farallon Capital Institutional Partners, L.P., Farallon Capital Institutional Partners II, L.P., Farallon Capital Institutional Partners III, L.P., Tinicum Partners, L.P., Farallon Capital Offshore Investors II, L.P., Farallon Capital Management, L.L.C., Farallon Partners, L.L.C., Chun R. Ding, William F. Duhamel, Richard B. Fried, Monica R. Landry, Douglas M. MacMahon, William F. Mellin, Stephen L. Millham, Jason E. Moment, Rajiv A. Patel, Derek C. Schrier, Thomas F. Steyer, Mark C. Wehrly | 30. März 2007 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 28. März 2007 | — | Erste Einreichung | Vorstandskampagne | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 12. Februar 2007 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 18. September 2006 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 10. August 2006 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 5. Dezember 2005 | — | Erste Einreichung | Vorstandskampagne | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 16. November 2005 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 7. November 2005 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 26. Oktober 2005 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 12. Oktober 2005 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 30. September 2005 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 23. September 2005 | — | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 79 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PJP · Invesco Exchange-Traded Fund Trust | 3,17% | 54.706 SH | 8. August 2026 | Täglich |
| PSCH · Invesco Exchange-Traded Fund Trust … | 2,97% | 17.394 SH | 8. August 2026 | Täglich |
| ALIL · EA Series Trust | 2,16% | 2.385 NS | 29. Mai 2026 | N-PORT |
| BBP · ETFis Series Trust I | 1,93% | 4.992 NS | 30. April 2026 | N-PORT |
| XSMO · Invesco Exchange-Traded Fund Trust | 1,88% | 198.917 SH | 8. August 2026 | Täglich |
| PTH · Invesco Exchange-Traded Fund Trust | 1,71% | 14.387 SH | 8. August 2026 | Täglich |
| PILL · Direxion Shares ETF Trust | 1,39% | 780 NS | 30. April 2026 | N-PORT |
| CAFG · Pacer Funds Trust | 1,33% | 1.317 NS | 30. April 2026 | N-PORT |
| IHE · iShares Trust | 1,33% | 71.583 SH | 8. August 2026 | Täglich |
| RZG · Invesco Exchange-Traded Fund Trust | 1,12% | 5.313 SH | 8. August 2026 | Täglich |
| GSC · Goldman Sachs ETF Trust | 1,04% | 11.355 NS | 31. Mai 2026 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund VI… | 0,82% | 1.851 NS | 31. Mai 2026 | N-PORT |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,69% | 23.854 SH | 8. August 2026 | Täglich |
| IJT · iShares Trust | 0,67% | 186.107 SH | 8. August 2026 | Täglich |
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,63% | 483 SH | 8. August 2026 | Täglich |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,51% | 23.394 NS | 30. April 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,44% | 6.688 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,40% | 1.093 SH | 8. August 2026 | Täglich |
| XJR · iShares Trust | 0,38% | 2.375 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,37% | 182.189 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,37% | 21.495 SH | 8. August 2026 | Täglich |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,34% | 70.067 SH | 8. August 2026 | Täglich |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,34% | 2.941 SH | 8. August 2026 | Täglich |
| IJR · iShares Trust | 0,33% | 1.222.161 SH | 8. August 2026 | Täglich |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,32% | 38.029 NS | 31. Mai 2026 | N-PORT |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,32% | 8.095 NS | 30. April 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,26% | 13.910 NS | 30. April 2026 | N-PORT |
| BFOR · ALPS ETF Trust | 0,26% | 2.424 NS | 31. Mai 2026 | N-PORT |
| BIB · ProShares Trust | 0,23% | 736 NS | 31. Mai 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,22% | 6.966 NS | 30. April 2026 | N-PORT |
| SAA · ProShares Trust | 0,20% | 236 NS | 31. Mai 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,20% | 702 NS | 30. April 2026 | N-PORT |
| SMLF · iShares Trust | 0,20% | 27.794 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,19% | 115.596 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,19% | 509.128 SH | 8. August 2026 | Täglich |
| GSSC · Goldman Sachs ETF Trust | 0,19% | 7.952 NS | 31. Mai 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,15% | 15.366 NS | 30. April 2026 | N-PORT |
| AFSM · First Trust Exchange-Traded Fund VI… | 0,14% | 597 NS | 31. Mai 2026 | N-PORT |
| RSSL · Global X Funds | 0,14% | 8.429 NS | 30. April 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,13% | 277.215 SH | 8. August 2026 | Täglich |
| ISCG · iShares Trust | 0,12% | 3.926 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,11% | 912 NS | 31. Mai 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,10% | 2.180 NS | 30. April 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,10% | 10.188 SH | 8. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,10% | 60.435 NS | 30. April 2026 | N-PORT |
| SMMV · iShares Trust | 0,10% | 934 SH | 8. August 2026 | Täglich |
| SCHA · SCHWAB STRATEGIC TRUST | 0,10% | 94.556 NS | 31. Mai 2026 | N-PORT |
| ISCB · iShares Trust | 0,09% | 887 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,09% | 58.421 SH | 8. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,07% | 9.071 NS | 30. April 2026 | N-PORT |